2024-11-18 LIDR Meeting Notes

Hung Luu

Children’s

Riki Merrick

Vernetzt, APHL

Andrea Pitkus

UW

Pam Banning

3M - Solventum

Xavier Gansel

Biomerieux

Amy McCormick

Epic

Dan Rutz

Epic

Rob Rae

CAP

Rob Hausam

Hausam Consulting

Sandy Jones

CDC

Stan Huff

Graphite

Ed Heierman

Abbott / IICC

Andrew Quinn

Laurent Lardin

Biomerieux

Anthony Killeen

UMN

Craig Collom

Marti Velezis

 Sonrisa / FDA

Walter Sujansky

FDA

Susan Downer

JMC

Ralf Herzog

Roche

Cornelia Felder

Roche

Daniel Golson

JMC

Andrea Prada

JMC

Maria Sagat

 CAP

Raja Cholan

FDA

Russ Ott

FDA

Akila Namasivayam

FDA

Desiree Mustaquim

CDC

Carmen Pugh

CDC

Christina Gallegos

APHL

John Spinosa

Lantana

Matthew Dietz

FDA

Call Schedule

send OOO via chat or email

 LIDR White Paper Review

Reviewing the comments on the LIDR White Paper = LIDR White Paper

• Diagram feedback follow up:

  • Updated diagram: https://aphlinformatics.atlassian.net/wiki/download/attachments/1938718763/LIDR Work Group_Figure 9.pptx?api=v2

  • we will use #2 slide

• Discussion around implementation

  • using LIDR ID in transmissions vs using the codes represented in the row of the unique entry

  • goal for transmission is using the entries represented in LIDR (compared to what folks are sending now)

  • look up would be based on the instrument + test kit combination

    • even if not yet adopted / implemented in LIS

  • testing for compliance will be different question - we are trying to enable the systems to have the content and configuration required to implement in the long term

  • separating methods from LOINC will be available but pre-coordination will still be supported

• Roadmap section:

  • Looks ok as is

• How to get involved section:

  • added sentence to reach out to laboratorians for their input

  • Looks ok

• Implementation Consideration section- added between Roadmap and How to get involved

  • Riki will write up strawman

  • include considerations around certification

  • differniate between system level and user level and include feasability of features and pilot testing

  • keep this short

Open To Dos:

• Riki to write the Implementation Consideration section

• Need to check reference style and pick one

• Reviewed comments on introduction - Still need to check for best place to talk about CLSI AUTO-16/IHE LAW (question: has anyone implemented in the US in production?)

• Andrea to write up her sentences as per comments

GOAL: Get to SC for their 12/3 call!!!

Review examples of merged cell LIVD file entries

https://aphlinformatics.atlassian.net/wiki/download/attachments/1938718763/Copy-HIV-Diagnostic-LOINC-Map_v5.xlsx?api=v2

essentially the repeating cells were merged for readability, they all would be separate LIVD file entries with the same UDI

Reviewing minutes from the last call - Action Item Follow up

• Pull out the definitions from LIVD for test kit and equipment and put here: SHIELD Glossary

  • Review operational definition of “equivalence”

• Outreach to Dr. DeBaca

  • Hung will check for more info and maybe see, if she could participate in SHIELD

• Keep updating the googlesheet: Potassium LIVD data

• Shared Reportable Conditions LIVD google sheet for crowdsourcing with CSTE - added sign up sheet for PHAs to specific conditions and see how that develops

• Have LIVD File Repository Requirements

  Have draft budget (for setting up a web-based database and yearly maintenance): https://aphlinformatics.atlassian.net/wiki/download/attachments/915407143/LIDR - Budget.xlsx?api=v2

• Define next steps to migrate existing LIVD files into FHIR LIVD catalog format and find a FHIR server to host

• Marti can share the LIDR categorical data to instance data mapping for each element - DATE?

ACTION ITEMS

All review the updated roadmap section and teh how to get inolved section and add feedback as comments on the page

Next call

Monday 11/25/2024 9:05 - 9:55 AM ET

Adjourned

9:57 AM ET